{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31567464", "DateCompleted": {"Year": "2020", "Month": "08", "Day": "03"}, "DateRevised": {"Year": "2020", "Month": "09", "Day": "01"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1097/PPO.0000000000000403"], "Journal": {"ISSN": "1540-336X", "JournalIssue": {"Volume": "25", "Issue": "5", "PubDate": {"Year": "2019", "Season": "Sep/Oct"}}, "Title": "Cancer journal (Sudbury, Mass.)", "ISOAbbreviation": "Cancer J"}, "ArticleTitle": "Practical Application of \"About Herbs\" Website: Herbs and Dietary Supplement Use in Oncology Settings.", "Pagination": {"StartPage": "357", "EndPage": "366", "MedlinePgn": "357-366"}, "Abstract": {"AbstractText": ["The Integrative Medicine Service at Memorial Sloan Kettering Cancer Center developed and maintains About Herbs (www.aboutherbs.com), which provides summaries of research data including purported uses, adverse effects, and herb-drug interactions for about 284 dietary supplements. Using Google Analytics, we found the website registered more than 26,317,000 hits since November 2002. The 10 most searched-for herbs/supplements of 2018 are chaga mushroom, turmeric, ashwagandha, reishi mushroom, graviola, Active Hexose-Correlated Compound, boswellia, dandelion, green tea, and Coriolus versicolor. Here we discuss their safety, herb-drug interactions, and appropriate uses in the oncology setting, based on literature searches in PubMed. Over the past 16 years, the evidence for use of these supplements is based mostly on preclinical findings, with few well-designed studies and limited trials conducted in cancer patients. It is important to familiarize health care professionals about popular supplements, so patients can be informed to make decisions that maximize benefits and minimize risks."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "From the Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY."}], "LastName": "Hou", "ForeName": "Yen-Nien", "Initials": "YN"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Deng", "ForeName": "Gary", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mao", "ForeName": "Jun J", "Initials": "JJ"}], "GrantList": [{"GrantID": "P30 CA008748", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Cancer J", "NlmUniqueID": "100931981", "ISSNLinking": "1528-9117"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["methods"], "DescriptorName": "Medical Oncology"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Web Browser"}], "CoiStatement": "Conflicts of Interest. The authors have no conflicts of interest to report."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Wu CH, Wang CC, Tsai MT, Huang WT, Kennedy J. Trend and pattern of herb and supplement use in the United States: results from the 2002, 2007, and 2012 national health interview surveys. Evid Based Complement Alternat Med 2014;2014:872320.", "ArticleIdList": ["PMC4276694", "25574184"]}, {"Citation": "Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat 10 2014:1\u2013161.", "ArticleIdList": ["24819891"]}, {"Citation": "Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 2008;26:665\u2013673.", "ArticleIdList": ["18235127"]}, {"Citation": "Giovannucci E, Chan AT. Role of vitamin and mineral supplementation and aspirin use in cancer survivors. J Clin Oncol 2010;28:4081\u20134085.", "ArticleIdList": ["PMC3385518", "20697066"]}, {"Citation": "Anderson JG, Taylor AG. Use of complementary therapies for cancer symptom management: results of the 2007 National Health Interview Survey. J Altern Complement Med 2012;18:235\u2013241.", "ArticleIdList": ["PMC3306580", "22420737"]}, {"Citation": "Ekor M The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014;4:177.", "ArticleIdList": ["PMC3887317", "24454289"]}, {"Citation": "D\u2019Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005;55:319\u2013321.", "ArticleIdList": ["16166076"]}, {"Citation": "Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004;22:2489\u20132503.", "ArticleIdList": ["15197212"]}, {"Citation": "Meijerman I, Beijnen JH, Schellens JH. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 2006;11:742\u2013752.", "ArticleIdList": ["16880233"]}, {"Citation": "Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol 2013;75:603\u2013618.", "ArticleIdList": ["PMC3575928", "22670731"]}, {"Citation": "Rozga MR, Stern JS, Stanhope K, Havel PJ, Kazaks AG. Dietary supplement users vary in attitudes and sources of dietary supplement information in East and West geographic regions: a cross-sectional study. BMC Complement Altern Med 2013;13:200.", "ArticleIdList": ["PMC3737081", "23899171"]}, {"Citation": "Alnemer KA, Alhuzaim WM, Alnemer AA, et al. Are Health-Related Tweets Evidence Based? Review and Analysis of Health-Related Tweets on Twitter. J Med Internet Res 2015;17:e246.", "ArticleIdList": ["PMC4642373", "26515535"]}, {"Citation": "Goldacre B Preventing bad reporting on health research. BMJ 2014;349:g7465.", "ArticleIdList": ["25498123"]}, {"Citation": "Cooper BE, Lee WE, Goldacre BM, Sanders TA. The quality of the evidence for dietary advice given in UK national newspapers. Public Underst Sci 2012;21:664\u2013673.", "ArticleIdList": ["23832153"]}, {"Citation": "Frenkel M, Ben-Arye E, Baldwin CD, Sierpina V. Approach to communicating with patients about the use of nutritional supplements in cancer care. South Med J 2005;98:289\u2013294.", "ArticleIdList": ["15813155"]}, {"Citation": "Tarn DM, Paterniti DA, Good JS, et al. Physician-patient communication about dietary supplements. Patient Educ Couns 2013;91:287\u2013294.", "ArticleIdList": ["PMC3648214", "23466249"]}, {"Citation": "Asher GN, Xie Y, Moaddel R, et al. Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers. J Clin Pharmacol 2017;57:185\u2013193.", "ArticleIdList": ["PMC5233601", "27503249"]}, {"Citation": "Shikov AN, Pozharitskaya ON, Makarov VG, Wagner H, Verpoorte R, Heinrich M. Medicinal plants of the Russian Pharmacopoeia; their history and applications. J Ethnopharmacol 2014;154:481\u2013536.", "ArticleIdList": ["24742754"]}, {"Citation": "Hyun KW, Jeong SC, Lee DH, Park JS, Lee JS. Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Peptides 2006;27:1173\u20131178.", "ArticleIdList": ["16289471"]}, {"Citation": "Ying YM, Zhang LY, Zhang X, et al. Terpenoids with alpha-glucosidase inhibitory activity from the submerged culture of Inonotus obliquus. Phytochemistry 2014;108:171\u2013176.", "ArticleIdList": ["25446238"]}, {"Citation": "Mishra SK, Kang JH, Kim DK, Oh SH, Kim MK. Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice. J Ethnopharmacol 2012;143:524\u2013532.", "ArticleIdList": ["22819687"]}, {"Citation": "Wang J, Hu W, Li L, et al. Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes. PLoS One 2017;12:e0180476.", "ArticleIdList": ["PMC5491251", "28662169"]}, {"Citation": "Lee SH, Hwang HS, Yun JW. Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells. Phytother Res 2009;23:1784\u20131789.", "ArticleIdList": ["19367670"]}, {"Citation": "Kang JH, Jang JE, Mishra SK, et al. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the beta-catenin pathway in colorectal cancer. J Ethnopharmacol 2015;173:303\u2013312.", "ArticleIdList": ["26210065"]}, {"Citation": "Lee HS, Kim EJ, Kim SH. Ethanol extract of Innotus obliquus (Chaga mushroom) induces G1 cell cycle arrest in HT-29 human colon cancer cells. Nutr Res Pract 2015;9:111\u2013116.", "ArticleIdList": ["PMC4388940", "25861415"]}, {"Citation": "Baek J, Roh HS, Baek KH, et al. Bioactivity-based analysis and chemical characterization of cytotoxic constituents from Chaga mushroom (Inonotus obliquus) that induce apoptosis in human lung adenocarcinoma cells. J Ethnopharmacol 2018;224:63\u201375.", "ArticleIdList": ["29800742"]}, {"Citation": "Youn MJ, Kim JK, Park SY, et al. Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by induction of apoptosis in melanoma B16-F10 cells. J Ethnopharmacol 2009;121:221\u2013228.", "ArticleIdList": ["19041933"]}, {"Citation": "Zhao LW, Zhong XH, Yang SY, Zhang YZ, Yang NJ. Inotodiol inhabits proliferation and induces apoptosis through modulating expression of cyclinE, p27, bcl-2, and bax in human cervical cancer HeLa cells. Asian Pac J Cancer Prev 2014;15:3195\u20133199.", "ArticleIdList": ["24815470"]}, {"Citation": "Kikuchi Y, Seta K, Ogawa Y, et al. Chaga mushroom-induced oxalate nephropathy. Clin Nephrol 2014;81:440\u2013444.", "ArticleIdList": ["23149251"]}, {"Citation": "Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging 2014;9:451\u2013458.", "ArticleIdList": ["PMC3964021", "24672232"]}, {"Citation": "Sahebkar A, Cicero AFG, Simental-Mendia LE, Aggarwal BB, Gupta SC. Curcumin downregulates human tumor necrosis factor-alpha levels: A systematic review and meta-analysis ofrandomized controlled trials. Pharmacol Res 2016;107:234\u2013242.", "ArticleIdList": ["27025786"]}, {"Citation": "Prakash P, Misra A, Surin WR, et al. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res 2011;127:111\u2013118.", "ArticleIdList": ["21144557"]}, {"Citation": "Jantan I, Raweh SM, Sirat HM, et al. Inhibitory effect of compounds from Zingiberaceae species on human platelet aggregation. Phytomedicine 2008;15:306\u2013309.", "ArticleIdList": ["17913483"]}, {"Citation": "Tang M, Larson-Meyer DE, Liebman M. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr 2008;87:1262\u20131267.", "ArticleIdList": ["18469248"]}, {"Citation": "Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther 2010;9:8\u201314.", "ArticleIdList": ["19901561"]}, {"Citation": "Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008;14:4491\u20134499.", "ArticleIdList": ["18628464"]}, {"Citation": "Kanai M, Yoshimura K, Asada M, et al. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol 2011;68:157\u2013164.", "ArticleIdList": ["20859741"]}, {"Citation": "Irving GR, Iwuji CO, Morgan B, et al. Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial. Trials 2015;16:110.", "ArticleIdList": ["PMC4392790", "25872567"]}, {"Citation": "Scontre VA, Martins JC, de Melo Sette CV, et al. Curcuma longa (Turmeric) for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Pilot Study. J Diet Suppl 2018;15:606\u2013612.", "ArticleIdList": ["29095653"]}, {"Citation": "Zhang W, Lim LY. Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro. Drug Metab Dispos 2008;36:1283\u20131290.", "ArticleIdList": ["18385293"]}, {"Citation": "Chen Y, Liu WH, Chen BL, et al. Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers. Ann Pharmacother 2010;44:1038\u20131045.", "ArticleIdList": ["20484172"]}, {"Citation": "Zhang W, Tan TM, Lim LY. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos 2007;35:110\u2013115.", "ArticleIdList": ["17050652"]}, {"Citation": "Al-Jenoobi FI, Al-Thukair AA, Alam MA, et al. Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects. Eur J Drug Metab Pharmacokinet 2015;40:61\u201366.", "ArticleIdList": ["24510399"]}, {"Citation": "Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res 2002;62:3868\u20133875.", "ArticleIdList": ["12097302"]}, {"Citation": "Teo YL, Ho HK, Chan A. Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations. Br J Clin Pharmacol 2015;79:241\u2013253.", "ArticleIdList": ["PMC4309630", "25125025"]}, {"Citation": "Appiah-Opong R, Commandeur JN, van Vugt-Lussenburg B, Vermeulen NP. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology 2007;235:83\u201391.", "ArticleIdList": ["17433521"]}, {"Citation": "Volak LP, Hanley MJ, Masse G, et al. Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2013;75:450\u2013462.", "ArticleIdList": ["PMC3579260", "22725836"]}, {"Citation": "Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 2000;5:334\u2013346.", "ArticleIdList": ["10956379"]}, {"Citation": "Davis L, Kuttan G. Effect of Withania somnifera on CTL activity. J Exp Clin Cancer Res 2002;21:115\u2013118.", "ArticleIdList": ["12071516"]}, {"Citation": "Prakash J, Gupta SK, Dinda AK. Withania somnifera root extract prevents DMBA-induced squamous cell carcinoma of skin in Swiss albino mice. Nutr Cancer 2002;42:91\u201397.", "ArticleIdList": ["12235655"]}, {"Citation": "Devi PU. Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Indian J Exp Biol 1996;34:927\u2013932.", "ArticleIdList": ["9055640"]}, {"Citation": "Panjamurthy K, Manoharan S, Menon VP, Nirmal MR, Senthil N. Protective role of withaferin-A on 7,12-dimethylbenz(a)anthracene-induced genotoxicity in bone marrow of Syrian golden hamsters. J Biochem Mol Toxicol 2008;22:251\u2013258.", "ArticleIdList": ["18752311"]}, {"Citation": "Li X, Zhu F, Jiang J, et al. Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells. Cancer Lett 2015;357:219\u2013230.", "ArticleIdList": ["25444914"]}, {"Citation": "Gupta YK, Sharma SS, Rai K, Katiyar CK. Reversal of paclitaxel induced neutropenia by Withania somnifera in mice. Indian J Physiol Pharmacol 2001;45:253\u2013257.", "ArticleIdList": ["11480235"]}, {"Citation": "Ramakanth GS, Uday Kumar C, Kishan PV, Usharani P. A randomized, double blind placebo controlled study of efficacy and tolerability of Withaina somnifera extracts in knee joint pain. J Ayurveda Integr Med 2016;7:151\u2013157.", "ArticleIdList": ["PMC5052364", "27647541"]}, {"Citation": "Biswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients. Integr Cancer Ther 2013;12:312\u2013322.", "ArticleIdList": ["23142798"]}, {"Citation": "Savai J, Varghese A, Pandita N, Chintamaneni M. Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes. Phytother Res 2015;29:785\u2013790.", "ArticleIdList": ["25684704"]}, {"Citation": "Lopresti AL, Drummond PD, Smith SJ. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males. Am J Mens Health 2019;13:1557988319835985.", "ArticleIdList": ["PMC6438434", "30854916"]}, {"Citation": "Shukla SD, Bhatnagar M, Khurana S. Critical evaluation of ayurvedic plants for stimulating intrinsic antioxidant response. Front Neurosci 2012;6:112.", "ArticleIdList": ["PMC3405414", "22855669"]}, {"Citation": "Guggenheim AG, Wright KM, Zwickey HL. Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology. Integr Med (Encinitas) 2014;13:32\u201344.", "ArticleIdList": ["PMC4684115", "26770080"]}, {"Citation": "Wang C, Shi S, Chen Q, et al. Antitumor and Immunomodulatory Activities of Ganoderma lucidum Polysaccharides in Glioma-Bearing Rats. Integr Cancer Ther 2018;17:674\u2013683.", "ArticleIdList": ["PMC6142075", "29607690"]}, {"Citation": "Wu K, Na K, Chen D, Wang Y, Pan H, Wang X. Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells. Int J Oncol 2018;53:2356\u20132368.", "ArticleIdList": ["PMC6203158", "30272272"]}, {"Citation": "Wachtel-Galor S, Szeto YT, Tomlinson B, Benzie IF. Ganoderma lucidum (\u2018Lingzhi\u2019); acute and short-term biomarker response to supplementation. Int J Food Sci Nutr 2004;55:75\u201383.", "ArticleIdList": ["14630595"]}, {"Citation": "Wachtel-Galor S, Tomlinson B, Benzie IF. Ganoderma lucidum (\u201cLingzhi\u201d), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr 2004;91:263\u2013269.", "ArticleIdList": ["14756912"]}, {"Citation": "Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 2003;32:201\u2013215.", "ArticleIdList": ["12916709"]}, {"Citation": "Sun LX, Li WD, Lin ZB, et al. Protection against lung cancer patient plasma-induced lymphocyte suppression by Ganoderma lucidum polysaccharides. Cell Physiol Biochem 2014;33:289\u2013299.", "ArticleIdList": ["24525691"]}, {"Citation": "Oka S, Tanaka S, Yoshida S, et al. A water-soluble extract from culture medium of Ganoderma lucidum mycelia suppresses the development of colorectal adenomas. Hiroshima J Med Sci 2010;59:1\u20136.", "ArticleIdList": ["20518254"]}, {"Citation": "Gordan JD, Chay WY, Kelley RK, Ko AH, Choo SP, Venook AP. \u201cAnd what other medications are you taking?\u201d. J Clin Oncol 2011;29:e288\u2013291.", "ArticleIdList": ["21245436"]}, {"Citation": "Yan B, Meng X, Shi J, Qin Z, Wei P, Lao L. Ganoderma lucidum spore induced CA72\u20134 elevation in gastrointestinal cancer: a five-case report. Integr Cancer Ther 2014;13:161\u2013166.", "ArticleIdList": ["24282100"]}, {"Citation": "Klupp NL, Chang D, Hawke F, et al. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev 2015:Cd007259.", "ArticleIdList": ["PMC6486141", "25686270"]}, {"Citation": "Jin X, Ruiz Beguerie J, Sze DM, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev 2016;4:Cd007731.", "ArticleIdList": ["PMC6353236", "27045603"]}, {"Citation": "Tao J, Feng KY. Experimental and clinical studies on inhibitory effect of ganoderma lucidum on platelet aggregation. J Tongji Med Univ 1990;10:240\u2013243.", "ArticleIdList": ["2098581"]}, {"Citation": "Wang X, Zhao X, Li D, Lou YQ, Lin ZB, Zhang GL. Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats. Biol Pharm Bull 2007;30:1702\u20131706.", "ArticleIdList": ["17827724"]}, {"Citation": "Clement YN, Mahase V, Jagroop A, et al. Herbal remedies and functional foods used by cancer patients attending specialty oncology clinics in Trinidad. BMC Complement Altern Med 2016;16:399.", "ArticleIdList": ["PMC5073821", "27769229"]}, {"Citation": "George VC, Kumar DR, Suresh PK, Kumar RA. Antioxidant, DNA protective efficacy and HPLC analysis of Annona muricata (soursop) extracts. J Food Sci Technol 2015;52:2328\u20132335.", "ArticleIdList": ["PMC4375238", "25829616"]}, {"Citation": "Qazi AK, Siddiqui JA, Jahan R, et al. Emerging therapeutic potential of graviola and its constituents in cancers. Carcinogenesis 2018;39:522\u2013533.", "ArticleIdList": ["PMC5888937", "29462271"]}, {"Citation": "de Sousa OV, Vieira GD, de Jesus RGdPJ, Yamamoto CH, Alves MS. Antinociceptive and anti-inflammatory activities of the ethanol extract of Annona muricata L. leaves in animal models. Int J Mol Sci 2010;11:2067\u20132078.", "ArticleIdList": ["PMC2885094", "20559502"]}, {"Citation": "Ishola IO, Awodele O, Olusayero AM, Ochieng CO. Mechanisms of analgesic and anti-inflammatory properties of Annona muricata Linn. (Annonaceae) fruit extract in rodents. J Med Food 2014;17:1375\u20131382.", "ArticleIdList": ["PMC4259190", "25133801"]}, {"Citation": "Moghadamtousi SZ, Rouhollahi E, Karimian H, Fadaeinasab M, Abdulla MA, Kadir HA. Gastroprotective activity of Annona muricata leaves against ethanol-induced gastric injury in rats via Hsp70/Bax involvement. Drug Des Devel Ther 2014;8:2099\u20132110.", "ArticleIdList": ["PMC4218895", "25378912"]}, {"Citation": "Dai Y, Hogan S, Schmelz EM, Ju YH, Canning C, Zhou K. Selective growth inhibition of human breast cancer cells by graviola fruit extract in vitro and in vivo involving downregulation of EGFR expression. Nutr Cancer 2011;63:795\u2013801.", "ArticleIdList": ["21767082"]}, {"Citation": "Moghadamtousi SZ, Kadir HA, Paydar M, Rouhollahi E, Karimian H. Annona muricata leaves induced apoptosis in A549 cells through mitochondrial-mediated pathway and involvement of NF-kappaB. BMC Complement Altern Med 2014;14:299.", "ArticleIdList": ["PMC4246449", "25127718"]}, {"Citation": "Zorofchian Moghadamtousi S, Karimian H, Rouhollahi E, Paydar M, Fadaeinasab M, Abdul Kadir H. Annona muricata leaves induce G(1) cell cycle arrest and apoptosis through mitochondria-mediated pathway in human HCT-116 and HT-29 colon cancer cells. J Ethnopharmacol 2014;156:277\u2013289.", "ArticleIdList": ["25195082"]}, {"Citation": "Torres MP, Rachagani S, Purohit V, et al. Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Lett 2012;323:29\u201340.", "ArticleIdList": ["PMC3371140", "22475682"]}, {"Citation": "Adeyemi DO, Komolafe OA, Adewole OS, Obuotor EM, Adenowo TK. Anti hyperglycemic activities of Annona muricata (Linn). Afr J Tradit Complement Altern Med 2008;6:62\u201369.", "ArticleIdList": ["PMC2816521", "20162043"]}, {"Citation": "Nwokocha CR, Owu DU, Gordon A, et al. Possible mechanisms of action of the hypotensive effect of Annona muricata (soursop) in normotensive Sprague-Dawley rats. Pharm Biol 2012;50:1436\u20131441.", "ArticleIdList": ["22950673"]}, {"Citation": "Ito T, Urushima H, Sakaue M, et al. Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy. Nutr Cancer 2014;66:377\u2013382.", "ArticleIdList": ["24611562"]}, {"Citation": "Suknikhom W, Lertkhachonsuk R, Manchana T. The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based Chemotherapy. Asian Pac J Cancer Prev 2017;18:633\u2013638.", "ArticleIdList": ["PMC5464477", "28440968"]}, {"Citation": "Ye SF, Ichimura K, Wakame K, Ohe M. Suppressive effects of Active Hexose Correlated Compound on the increased activity of hepatic and renal ornithine decarboxylase induced by oxidative stress. Life Sci 2003;74:593\u2013602.", "ArticleIdList": ["14623030"]}, {"Citation": "Mascaraque C, Suarez MD, Zarzuelo A, Sanchez de Medina F, Martinez-Augustin O. Active hexose correlated compound exerts therapeutic effects in lymphocyte driven colitis. Mol Nutr Food Res 2014;58:2379\u20132382.", "ArticleIdList": ["25186628"]}, {"Citation": "Aviles H, Belay T, Fountain K, Vance M, Sun B, Sonnenfeld G. Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol (1985) 2003;95:491\u2013496.", "ArticleIdList": ["12692142"]}, {"Citation": "Wang S, Welte T, Fang H, et al. Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice. J Nutr 2009;139:598\u2013602.", "ArticleIdList": ["PMC2646222", "19141700"]}, {"Citation": "Yagita A, Maruyama S, Wakasugi S, Sukegawa Y. H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts. In Vivo 2002;16:49\u201354.", "ArticleIdList": ["11980361"]}, {"Citation": "Suenaga S, Kuramitsu Y, Kaino S, et al. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine. Anticancer Res 2014;34:141\u2013146.", "ArticleIdList": ["24403454"]}, {"Citation": "Kuhara K, Tokuda K, Kitagawa T, et al. CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells. Anticancer Res 2018;38:6107\u20136111.", "ArticleIdList": ["30396925"]}, {"Citation": "Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice. Toxicol Appl Pharmacol 2007;222:152\u2013158.", "ArticleIdList": ["17555784"]}, {"Citation": "Roman BE, Beli E, Duriancik DM, Gardner EM. Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine. Nutr Res 2013;33:12\u201317.", "ArticleIdList": ["23351405"]}, {"Citation": "Yin Z, Fujii H, Walshe T. Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-gamma and/or tumor necrosis factor-alpha in healthy adults. Hum Immunol 2010;71:1187\u20131190.", "ArticleIdList": ["20732368"]}, {"Citation": "Terakawa N, Matsui Y, Satoi S, et al. Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. Nutr Cancer 2008;60:643\u2013651.", "ArticleIdList": ["18791928"]}, {"Citation": "Matsui Y, Uhara J, Satoi S, et al. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study. J Hepatol 2002;37:78\u201386.", "ArticleIdList": ["12076865"]}, {"Citation": "Yanagimoto H, Satoi S, Yamamoto T, et al. Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma. Nutr Cancer 2016;68:234\u2013240.", "ArticleIdList": ["26847832"]}, {"Citation": "Mach CM, Fugii H, Wakame K, Smith J. Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents. J Soc Integr Oncol 2008;6:105\u2013109.", "ArticleIdList": ["19087767"]}, {"Citation": "Mathew L, Gaikwad A, Gonzalez A, Nugent EK, Smith JA. Evaluation of Active Hexose Correlated Compound (AHCC) in Combination With Anticancer Hormones in Orthotopic Breast Cancer Models. Integr Cancer Ther 2017;16:300\u2013307.", "ArticleIdList": ["PMC5759944", "28438054"]}, {"Citation": "Dahmen U, Gu YL, Dirsch O, et al. Boswellic acid, a potent antiinflammatory drug, inhibits rejection to the same extent as high dose steroids. Transplant Proc 2001;33:539\u2013541.", "ArticleIdList": ["11266947"]}, {"Citation": "Safayhi H, Boden SE, Schweizer S, Ammon HP. Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL. Planta Med 2000;66:110\u2013113.", "ArticleIdList": ["10763581"]}, {"Citation": "Glaser T, Winter S, Groscurth P, et al. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br J Cancer 1999;80:756\u2013765.", "ArticleIdList": ["PMC2362292", "10360653"]}, {"Citation": "Jing Y, Nakajo S, Xia L, et al. Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines. Leuk Res 1999;23:43\u201350.", "ArticleIdList": ["9933134"]}, {"Citation": "Winking M, Sarikaya S, Rahmanian A, Jodicke A, Boker DK. Boswellic acids inhibit glioma growth: a new treatment option? J Neurooncol 2000;46:97\u2013103.", "ArticleIdList": ["10894362"]}, {"Citation": "Conti S, Vexler A, Edry-Botzer L, et al. Combined acetyl-11-keto-beta-boswellic acid and radiation treatment inhibited glioblastoma tumor cells. PLoS One 2018;13:e0198627.", "ArticleIdList": ["PMC6029770", "29969452"]}, {"Citation": "Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther 2008;10:R85.", "ArticleIdList": ["PMC2575633", "18667054"]}, {"Citation": "Kirste S, Treier M, Wehrle SJ, et al. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer 2011;117:3788\u20133795.", "ArticleIdList": ["21287538"]}, {"Citation": "Togni S, Maramaldi G, Bonetta A, Giacomelli L, Di Pierro F. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial. Eur Rev Med Pharmacol Sci 2015;19:1338\u20131344.", "ArticleIdList": ["25967706"]}, {"Citation": "Holtmeier W, Zeuzem S, Preiss J, et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn\u2019s disease: good safety profile but lack of efficacy. Inflamm Bowel Dis 2011;17:573\u2013582.", "ArticleIdList": ["20848527"]}, {"Citation": "Acebo E, Raton JA, Sautua S, Eizaguirre X, Trebol I, Perez JL. Allergic contact dermatitis from Boswellia serrata extract in a naturopathic cream. Contact Dermatitis 2004;51:91\u201392.", "ArticleIdList": ["15373853"]}, {"Citation": "Kokkiripati PK, Bhakshu LM, Marri S, et al. Gum resin of Boswellia serrata inhibited human monocytic (THP-1) cell activation and platelet aggregation. J Ethnopharmacol 2011;137:893\u2013901.", "ArticleIdList": ["21771654"]}, {"Citation": "Bensky D, Clavey S, St\u00f6ger E. Chinese Herbal Medicine, Materia Medica. 3rd ed. Seattle, WA: Eastland Press, Inc; 2004."}, {"Citation": "Clare BA, Conroy RS, Spelman K. The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day. J Altern Complement Med 2009;15:929\u2013934.", "ArticleIdList": ["PMC3155102", "19678785"]}, {"Citation": "Martinez M, Poirrier P, Chamy R, et al. Taraxacum officinale and related species-An ethnopharmacological review and its potential as a commercial medicinal plant. J Ethnopharmacol 2015;169:244\u2013262.", "ArticleIdList": ["25858507"]}, {"Citation": "Hata K, Ishikawa K, Hori K, Konishi T. Differentiation-inducing activity of lupeol, a lupane-type triterpene from Chinese dandelion root (Hokouei-kon), on a mouse melanoma cell line. Biol Pharm Bull 2000;23:962\u2013967.", "ArticleIdList": ["10963304"]}, {"Citation": "Ovadje P, Chochkeh M, Akbari-Asl P, Hamm C, Pandey S. Selective induction of apoptosis and autophagy through treatment with dandelion root extract in human pancreatic cancer cells. Pancreas 2012;41:1039\u20131047.", "ArticleIdList": ["22647733"]}, {"Citation": "Ovadje P, Ammar S, Guerrero JA, Arnason JT, Pandey S. Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways. Oncotarget 2016;7:73080\u201373100.", "ArticleIdList": ["PMC5341965", "27564258"]}, {"Citation": "Ovadje P, Hamm C, Pandey S. Efficient induction of extrinsic cell death by dandelion root extract in human chronic myelomonocytic leukemia (CMML) cells. PLoS One 2012;7:e30604.", "ArticleIdList": ["PMC3281857", "22363452"]}, {"Citation": "Rahmat LT, Damon LE. The Use of Natural Health Products Especially Papaya Leaf Extract and Dandelion Root Extract in Previously Untreated Chronic Myelomonocytic Leukemia. Case reports in hematology 2018;2018:7267920.", "ArticleIdList": ["PMC6312608", "30662779"]}, {"Citation": "Oh SM, Kim HR, Park YJ, Lee YH, Chung KH. Ethanolic extract of dandelion (Taraxacum mongolicum) induces estrogenic activity in MCF-7 cells and immature rats. Chinese journal of natural medicines 2015;13:808\u2013814.", "ArticleIdList": ["26614455"]}, {"Citation": "Maliakal PP, Wanwimolruk S. Effect of herbal teas on hepatic drug metabolizing enzymes in rats. J Pharm Pharmacol 2001;53:1323\u20131329.", "ArticleIdList": ["11697539"]}, {"Citation": "Dufay S, Worsley A, Monteillier A, et al. Herbal tea extracts inhibit Cytochrome P450 3A4 in vitro. J Pharm Pharmacol 2014;66:1478\u20131490.", "ArticleIdList": ["24824478"]}, {"Citation": "Kumar NB, Pow-Sang J, Egan KM, et al. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Cancer Prev Res (Phila) 2015;8:879\u2013887.", "ArticleIdList": ["PMC4596745", "25873370"]}, {"Citation": "Shanafelt TD, Call TG, Zent CS, et al. Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer 2013;119:363\u2013370.", "ArticleIdList": ["PMC3902473", "22760587"]}, {"Citation": "Thomas R, Williams M, Sharma H, Chaudry A, Bellamy P. A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer--the U.K. NCRN Pomi-T study. Prostate Cancer Prostatic Dis 2014;17:180\u2013186.", "ArticleIdList": ["PMC4020278", "24614693"]}, {"Citation": "Chow HH, Hakim IA, Vining DR, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 2005;11:4627\u20134633.", "ArticleIdList": ["15958649"]}, {"Citation": "Naumovski N, Blades BL, Roach PD. Food Inhibits the Oral Bioavailability of the Major Green Tea Antioxidant Epigallocatechin Gallate in Humans. Antioxidants (Basel, Switzerland) 2015;4:373\u2013393.", "ArticleIdList": ["PMC4665468", "26783711"]}, {"Citation": "Golden EB, Lam PY, Kardosh A, et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009;113:5927\u20135937.", "ArticleIdList": ["19190249"]}, {"Citation": "Misaka S, Kawabe K, Onoue S, et al. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug Metab Pharmacokinet 2013;28:244\u2013249.", "ArticleIdList": ["23268924"]}, {"Citation": "Lee MJ, Maliakal P, Chen L, et al. Pharmacokinetics of tea catechins after ingestion of green tea and (\u2212)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002;11:1025\u20131032.", "ArticleIdList": ["12376503"]}, {"Citation": "Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, Schantz SP. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 1998;7:351\u2013354.", "ArticleIdList": ["9568793"]}, {"Citation": "Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet 1994;343:1122\u20131126.", "ArticleIdList": ["7910230"]}, {"Citation": "Niimoto M, Hattori T, Tamada R, Sugimachi K, Inokuchi K, Ogawa N. Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years. Jpn J Surg 1988;18:681\u2013686.", "ArticleIdList": ["3150019"]}, {"Citation": "Ohwada S, Ikeya T, Yokomori T, et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer 2004;90:1003\u20131010.", "ArticleIdList": ["PMC2409633", "14997197"]}, {"Citation": "Mitomi T, Tsuchiya S, Iijima N, et al. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). Dis Colon Rectum 1992;35:123\u2013130.", "ArticleIdList": ["1735313"]}, {"Citation": "Torisu M, Hayashi Y, Ishimitsu T, et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 1990;31:261\u2013268.", "ArticleIdList": ["PMC11038516", "2198088"]}, {"Citation": "Ogoshi K, Satou H, Isono K, Mitomi T, Endoh M, Sugita M. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan. Am J Clin Oncol 1995;18:216\u2013222.", "ArticleIdList": ["7747709"]}, {"Citation": "Tsang KW, Lam CL, Yan C, et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med 2003;97:618\u2013624.", "ArticleIdList": ["12814145"]}, {"Citation": "Wong CK, Tse PS, Wong EL, Leung PC, Fung KP, Lam CW. Immunomodulatory effects of yun zhi and danshen capsules in health subjects--a randomized, double-blind, placebo-controlled, crossover study. Int Immunopharmacol 2004;4:201\u2013211.", "ArticleIdList": ["14996412"]}, {"Citation": "Wong CK, Bao YX, Wong EL, Leung PC, Fung KP, Lam CW. Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med 2005;33:381\u2013395.", "ArticleIdList": ["16047556"]}, {"Citation": "Iino Y, Yokoe T, Maemura M, et al. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer. Anticancer Res 1995;15:2907\u20132911.", "ArticleIdList": ["8669887"]}, {"Citation": "Suto T, Fukuda S, Moriya N, et al. Clinical study of biological response modifiers as maintenance therapy for hepatocellular carcinoma. Cancer Chemother Pharmacol 1994;33 Suppl:S145\u2013148.", "ArticleIdList": ["8137477"]}, {"Citation": "Chay WY, Tham CK, Toh HC, et al. Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function or Who Are Unfit for Standard Therapy. J Altern Complement Med 2017;23:648\u2013652.", "ArticleIdList": ["28375640"]}, {"Citation": "Ohno R, Yamada K, Masaoka T, et al. A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation. Cancer Immunol Immunother 1984;18:149\u2013154.", "ArticleIdList": ["PMC11039289", "6391658"]}, {"Citation": "Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 2000;5:4\u201327.", "ArticleIdList": ["10696116"]}]}], "History": [{"Year": "2019", "Month": "10", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31567464", "NIHMS1536732", "PMC6777855", "10.1097/PPO.0000000000000403", "00130404-201909000-00010"]}}]}